Abstract
TSH-suppressive therapy and the increased risk of cardiovascular disease in patients with differentiated thyroid cancer (DTC) was previously reported. A recent study by Pajamaki and colleagues found that patients with DTC have a higher risk of atrial fibrillation but a lower all-cause cardiovascular death rate. This study offers insights into this effect.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nature clinical practice. Endocrinology & metabolism
Paper Title
Journal
Date
